Related Experiment Video
Updated: Jul 5, 2026
05:02
Listeria monocytogenes Infection of the Brain
Published on: October 2, 2018
First Trimester Listeria monocytogenes Septicemia
M Goddijn1, H G Schipper, L Spanjaard
1Department of Obstetrics and Gynecology (H4-205) Academic Medical Center University of Amsterdam PO Box 22700 Amsterdam 1100 DE The Netherlands.
Infectious Diseases in Obstetrics and Gynecology
|January 1, 1997
Summary
Maternal Listeria monocytogenes septicemia in early pregnancy can have a normal fetal outcome with prompt amoxicillin treatment. This case highlights successful management during embryogenesis, leading to a healthy infant.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Perinatal Medicine
Background:
- Limited data exists on fetal outcomes following Listeria monocytogenes septicemia during the first trimester.
- Listeria monocytogenes infections during pregnancy pose risks to both mother and fetus.
Purpose of the Study:
- To report on the fetal outcome of a pregnancy complicated by Listeria monocytogenes septicemia in the first trimester.
- To assess the efficacy of amoxicillin treatment in managing maternal Listeria monocytogenes infection during early pregnancy.
Main Methods:
- A case report of a primigravida diagnosed with Listeria monocytogenes septicemia at 9 weeks gestation.
- Treatment administered included amoxicillin for the maternal infection.
Main Results:
- The patient received amoxicillin treatment for Listeria monocytogenes septicemia.
- A healthy female infant was delivered at 40 weeks gestation.
Conclusions:
- Appropriate antibiotic treatment of maternal Listeria monocytogenes septicemia during early pregnancy (embryogenesis) can lead to a normal fetal outcome.
- This case suggests that Listeria monocytogenes infection in the first trimester is manageable with timely intervention.
Related Concept Videos
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...